glp 1 agonist vs metformin decreases liver production of glucose and improves tissue insulin sensitivity. Metformin can assist with weight management, especially if significant insulin resistance (IR) and can regulate menstrual cycles, improve fertility and decrease Current Insights, Advantages and Challenges

The development of dual GIPRGLP1R coagonists that bind to either one or the other receptor (sequence-mixed dual agonists) has emerged as an innovative therapeutic strategy for obesity and type 2 diabetes

Tirzepatide), metabolic outcomes, and next-gen weight loss benefits

Tirzepatide & Semaglutide Options Price: Starting at $100/month

Certainly, the apparent advantage of tirzepatide, a dual incretin agonist, over GLP-1RA will spark renewed interest in the therapeutic potential of GIP in type 2 diabetes, obesity and related co-morbidities.

Overall, the EASD-ADA consensus provides a dynamic framework that supports a multifaceted, patient-centric approach to type 2 diabetes care, aiming to reduce complications, improve quality of life, and promote long-term health outcomes

Week 2+: Regular daily movements, burps gone, sustained energy and mental clarity